|4Feb 8, 5:33 PM ET

Engelson Erik T. 4

4 · Lucira Health, Inc. · Filed Feb 8, 2021

Insider Transaction Report

Form 4
Period: 2021-02-04
Engelson Erik T.
DirectorPresident and Chief Executive
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-04+173,937173,937 total
    Exercise: $17.00Exp: 2031-02-03Common Stock (173,937 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying this option shall vest on the first annual anniversary of the grant date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION